Search Results

Tizoxanide 50mg  | ≥98%

CSNpharm

Tizoxanide is an active metabolite of Nitazoxanide with inhibitory effect against hepatitis B virus and hepatitis C virus.

More Information Supplier Page

Tizoxanide 5mg  | ≥98%

CSNpharm

Tizoxanide is an active metabolite of Nitazoxanide with inhibitory effect against hepatitis B virus and hepatitis C virus.

More Information Supplier Page

Favipiravir 5mg  | ≥99%

CSNpharm

Favipiravir is an anti-viral compound with activity against many RNA viruses and an RNA-directed RNA polymerase NS5B inhibitor.

More Information Supplier Page

Favipiravir 100mg  | ≥99%

CSNpharm

Favipiravir is an anti-viral compound with activity against many RNA viruses and an RNA-directed RNA polymerase NS5B inhibitor.

More Information Supplier Page

Niflumic Acid 25mg  | ≥99%

CSNpharm

Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

More Information Supplier Page

Niflumic Acid 100mg  | ≥99%

CSNpharm

Niflumic acid, a Ca2+-activated Cl- channel blocker, is an analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.

More Information Supplier Page

Plerixafor 50mg  | ≥99%

CSNpharm

Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 100mg  | ≥99%

CSNpharm

Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 5mg  | ≥99%

CSNpharm

Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page

Plerixafor 10mg  | ≥99%

CSNpharm

Plerixafor is a chemokine receptor antagonist for CXCR4 and CXCL12-mediated chemotaxis with IC50 of 44 nM and 5.7 nM, respectively.

More Information Supplier Page